ANNOUNCEMENT

MedCity CONVERGE brings together the entire ecosystem to discuss Healthcare Innovation this July.

Topic: pharma

Lilly’s experimental rheumatoid arthritis drug effective in mid-stage study

Lilly’s experimental rheumatoid arthritis drug effective in mid-stage study

June 13, 2013 7:43 am by | 0 Comments

(Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment.The drug, baricitinib, ... Read more
Oncolytics gets good news on cancer drug Reolysin

Oncolytics gets good news on cancer drug Reolysin

May 22, 2013 9:46 am by | 0 Comments

(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients ... Read more
Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

Pfizer lets shareholders swap Pfizer stock for Zoetis stock with discount

May 22, 2013 8:52 am by | 0 Comments

(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for ... Read more
After tough times last year, Peregrine Pharma reaches agreement with FDA on late-stage trial for lung cancer drug

After tough times last year, Peregrine Pharma reaches agreement with FDA on late-stage trial for lung cancer drug

May 20, 2013 9:40 am by | 0 Comments

(Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug.The late-stage ... Read more
Experimental insomnia drug appears effective, but FDA question dosing levels

Experimental insomnia drug appears effective, but FDA question dosing levels

May 20, 2013 8:59 am by | 0 Comments

(Reuters) - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels.The ... Read more
Elan fends off takeover bid, plans acquisitions

Elan fends off takeover bid, plans acquisitions

May 20, 2013 2:12 am by | 0 Comments

DUBLIN (Reuters) - Elan will still have $1.2 billion of cash left to spend if shareholders approve its first package of acquisitions, and plans to announce more deals in the ... Read more
Sanofi plans regulatory filings for myelofibrosis drug treatment after successful drug trial

Sanofi plans regulatory filings for myelofibrosis drug treatment after successful drug trial

May 18, 2013 10:00 am by | 0 Comments

PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positive results.Myelofibrosis is a rare, life-threatening condition that involves ... Read more
Bayer acne drug deemed safe treatment for some women

Bayer acne drug deemed safe treatment for some women

May 17, 2013 8:26 am by | 0 Comments

LONDON (Reuters) - Bayer's acne pill Diane 35 and its generic versions are safe to use in certain women when other options have failed, the European Medicines Agency said on ... Read more
Key stakeholder Teva tries to stay out of limelight in drug controversy

Key stakeholder Teva tries to stay out of limelight in drug controversy

May 17, 2013 5:14 am by | 0 Comments

The recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles. But Teva Pharmaceuticals Ltd., which makes the drug and ... Read more
Doctors divided on usefulness of pollen count app for smartphones

Doctors divided on usefulness of pollen count app for smartphones

May 17, 2013 3:37 am by | 0 Comments

Kate O'Reilly's spring allergy survival kit includes the usual stuff -- nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line ... Read more
Adding plant-derived steroids to red yeast rice doesn’t help lower LDL levels

Adding plant-derived steroids to red yeast rice doesn’t help lower LDL levels

May 16, 2013 1:44 pm by | 0 Comments

NEW YORK (Reuters Health) - Adding a plant-derived compound called a sterol to the cholesterol-lowering agent red yeast rice doesn't make it work any better, according to a new study."I ... Read more
Bayer will buy German herbal medicine maker Steigerwald

Bayer will buy German herbal medicine maker Steigerwald

May 16, 2013 7:44 am by | 0 Comments

FRANKFURT (Reuters) - Germany's largest drugmaker Bayer said it agreed to buy privately held Steigerwald Arzneimittelwerk GmbH, a maker of herbal treatments.Bayer said on Thursday that Steigerwald, based in Darmstadt, ... Read more
AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

AstraZeneca needs new new products as others lose patent protection, accelerates drug pipeline

May 16, 2013 6:10 am by | 0 Comments

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers ... Read more
Drugmakers face more scrutiny of discordant U.S. prices

Drugmakers face more scrutiny of discordant U.S. prices

May 10, 2013 2:26 pm by | 0 Comments

LOS ANGELES (Reuters) - The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end.Companies ... Read more
Actavis in talks to acquire Warner Chilcott: report

Actavis in talks to acquire Warner Chilcott: report

May 10, 2013 1:25 pm by | 0 Comments

(Reuters) - Generic drugmaker Actavis Inc, formerly Watson Pharmaceuticals, is in early talks to acquire specialty pharmaceutical company Warner Chilcott Plc, according to a report from Bloomberg News.The discussions follow ... Read more